Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of ADR-002K for Patients With Ischemic Cardiomyopathy Who Undergo Coronary Artery Bypass Surgery

NCT04695522 is registered in ClinicalTrials.gov with Osaka University as lead sponsor.

NCT NCT04695522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04695522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of ADR-002K for Patients With Ischemic Cardiomyopathy Who Undergo Coronary Artery Bypass Surgery
Lead sponsor
Osaka University
Phase
Phase 1
Overall status
Unknown status
Start date
November 27, 2019
Completion date
October 31, 2021
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

d017202